Materiovigilance Programme of India: Current status and way forward.

Autor:	Saifuddin, P, Tandon, Moksh, Kalaiselvan, Vivekanandan, Suroy, Benjamin, Pattanshetti, Vidya, Prakash, Ajay, Medhi, Bikash
Předmět:	ADVERSE health care events DEVELOPED countries INSULIN aspart
Zdroj:	Indian Journal of Pharmacology; May/Jun2022, Vol. 54 Issue 3, p221-225, 5p
Abstrakt:	Postmarketing vigilance system for medical devices in India is not as vigorous as of drugs. W Materiovigilance involves post marketing surveillance of adverse events caused by medical devices. As per directive of WHO, many countries including India have established their own post marketing surveillance system. In India it is known as Materiovigilance Programme of India (MvPI). This article reviews the current state of MvPI, compares it with developed countries, identifies gaps, and recommends specific measure to strengthen the existing program. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.